- Report
- August 2022
- 87 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Report
- April 2021
- 30 Pages
Global
From €2867EUR$3,000USD£2,439GBP
- Drug Pipelines
- February 2018
- 50 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Report
- January 2022
- 80 Pages
Africa
From €3627EUR$3,795USD£3,086GBP
- Report
- January 2022
- 40 Pages
Brazil
From €2480EUR$2,595USD£2,110GBP
- Report
- January 2022
- 40 Pages
China
From €2480EUR$2,595USD£2,110GBP
- Report
- January 2022
- 40 Pages
France
From €2480EUR$2,595USD£2,110GBP
- Report
- January 2022
- 40 Pages
Germany
From €2480EUR$2,595USD£2,110GBP
- Report
- January 2022
- 40 Pages
Ireland
From €2480EUR$2,595USD£2,110GBP
- Report
- January 2022
- 40 Pages
Japan
From €2480EUR$2,595USD£2,110GBP
- Report
- January 2022
- 40 Pages
Russia
From €2480EUR$2,595USD£2,110GBP
- Report
- January 2022
- 40 Pages
South Korea
From €2480EUR$2,595USD£2,110GBP
- Report
- January 2022
- 40 Pages
United States
From €2480EUR$2,595USD£2,110GBP
- Report
- January 2022
- 40 Pages
Vietnam
From €2480EUR$2,595USD£2,110GBP
- Report
- March 2024
- 132 Pages
Global
From €908EUR$950USD£772GBP
- Report
- November 2023
- 215 Pages
China
From €3823EUR$4,000USD£3,252GBP
- Report
- November 2023
- 109 Pages
China
From €1720EUR$1,800USD£1,464GBP
- Report
- May 2023
- 268 Pages
Global
From €3412EUR$3,570USD£2,903GBP
- Report
- December 2019
- 222 Pages
Global
From €5132EUR$5,370USD£4,366GBP
Calcium Channel Blockers (CCBs) are a class of drugs used to treat cardiovascular diseases such as hypertension, angina, and arrhythmias. They work by blocking the entry of calcium ions into the cells of the heart and blood vessels, thus reducing the force of contraction of the heart and dilating the blood vessels. This reduces the workload on the heart and lowers blood pressure. CCBs are also used to treat other conditions such as migraine headaches and Raynaud's phenomenon.
CCBs are generally well tolerated and have few side effects. Common side effects include dizziness, headache, and swelling of the ankles. They may also interact with other medications, so it is important to discuss all medications with a doctor before taking CCBs.
The CCB market is a major component of the cardiovascular drug market. It is a highly competitive market, with many companies offering a variety of CCBs. Some of the major companies in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more